Zelapar (selegiline) Treatment Report
Generic Name: Selegiline
What is Zelapar?
Zelapar™ is a brand name for the drug selegiline, a Monoamine Oxidase (MAO) Type B inhibitor which slows the breakdown of levodopa. Used in combination with levodopa containing drugs such as Sinemet it can improve their efficacy.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat Parkinson's | 29 |
|
|
3 | |||
| Stiffness/Spasticity | 1 | 0 | |||||
| Don't know | 1 | 0 |
Mouse over the table for more information
Dosages
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
4 | 33% |
|
|
Doctor's advice
|
4 | 33% |
|
|
Other
|
3 | 25% |
|
|
Side effects too severe
|
2 | 17% |
|
|
Expense
|
1 | 8% |
|
|
Personal research
|
1 | 8% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 3 patient evaluations
-
- dixie pixie
- Sex: F
- Mouth/throat: mild
- Arms: mild
- Chest: mild
- Legs: mild
- See profile
-
-
- dixie pixie
- 1.5 mg daily
- since Apr 07, 2008
-
Efficacy
Can't tell
for Treat Parkinson's
-
Side Effects
None
- See full evaluation
-
- Goodpenny
- Sex: F
- Mouth/throat: mild
- Arms: mild
- Chest: mild
- Legs: mild
- See profile
-
-
- Goodpenny
- 2.5 mg daily
- since Aug 11, 2009
-
Efficacy
Major
for Treat Parkinson's
-
Side Effects
None
- See full evaluation
See all 3 patient evaluations
Report created on November 22, 2009.